$BPTH
BIO-PATH HOLDINGS, INC.

2022 Q1 Form 10-Q Financial Statement

#000155837022008980 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.261M $1.190M
YoY Change 5.97% -11.19%
% of Gross Profit
Research & Development $2.098M $1.261M
YoY Change 66.38% -37.26%
% of Gross Profit
Depreciation & Amortization $22.00K $18.00K
YoY Change 22.22% -10.0%
% of Gross Profit
Operating Expenses $3.359M $2.448M
YoY Change 37.21% -26.71%
Operating Profit -$3.359M -$2.448M
YoY Change 37.21%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $1.000K
YoY Change
Pretax Income -$3.359M -$2.450M
YoY Change 37.1% -26.2%
Income Tax
% Of Pretax Income
Net Earnings -$3.359M -$2.447M
YoY Change 37.27% -26.3%
Net Earnings / Revenue
Basic Earnings Per Share -$0.47 -$0.43
Diluted Earnings Per Share -$0.47 -$0.43
COMMON SHARES
Basic Shares Outstanding 7.160M 5.721M
Diluted Shares Outstanding 7.160M 5.721M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.25M $30.79M
YoY Change -30.99% 72.11%
Cash & Equivalents $21.25M $30.79M
Short-Term Investments
Other Short-Term Assets $1.410M $1.830M
YoY Change -22.95% 40.77%
Inventory
Prepaid Expenses $952.0K
Receivables
Other Receivables
Total Short-Term Assets $23.61M $32.62M
YoY Change -27.62% 69.98%
LONG-TERM ASSETS
Property, Plant & Equipment $203.0K $480.0K
YoY Change -57.71% -23.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $468.0K $480.0K
YoY Change -2.5% -25.0%
TOTAL ASSETS
Total Short-Term Assets $23.61M $32.62M
Total Long-Term Assets $468.0K $480.0K
Total Assets $24.08M $33.10M
YoY Change -27.26% 66.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $390.0K
YoY Change 2.56% -52.44%
Accrued Expenses $1.100M $1.120M
YoY Change -1.79% 45.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.568M $1.520M
YoY Change 3.16% -4.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $195.0K $210.0K
YoY Change -7.14% -32.26%
Total Long-Term Liabilities $195.0K $210.0K
YoY Change -7.14% -32.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.568M $1.520M
Total Long-Term Liabilities $195.0K $210.0K
Total Liabilities $1.763M $1.730M
YoY Change 1.91% -8.47%
SHAREHOLDERS EQUITY
Retained Earnings -$81.02M
YoY Change
Common Stock $7.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.32M $31.37M
YoY Change
Total Liabilities & Shareholders Equity $24.08M $33.10M
YoY Change -27.26% 66.92%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$3.359M -$2.447M
YoY Change 37.27% -26.3%
Depreciation, Depletion And Amortization $22.00K $18.00K
YoY Change 22.22% -10.0%
Cash From Operating Activities -$2.526M -$1.572M
YoY Change 60.69% -38.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $12.20M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 18.61M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.526M -1.572M
Cash From Investing Activities
Cash From Financing Activities 0.000 18.61M
Net Change In Cash -2.526M 17.04M
YoY Change -114.83% -770.79%
FREE CASH FLOW
Cash From Operating Activities -$2.526M -$1.572M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7160000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5721000
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7160000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7160000
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bellaire
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
BIO-PATH HOLDINGS INC
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001133818
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-36333
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0652870
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4710 Bellaire Boulevard, Suite 210
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77401
CY2022Q1 dei City Area Code
CityAreaCode
832
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
742-1357
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
BPTH
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7160164
CY2022Q1 us-gaap Cash
Cash
21248000
CY2021Q4 us-gaap Cash
Cash
23774000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
952000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
523000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1410000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1843000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
23610000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
26140000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1099000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1099000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
896000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
874000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
203000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
225000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
265000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
203000
CY2022Q1 us-gaap Assets
Assets
24078000
CY2021Q4 us-gaap Assets
Assets
26568000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
409000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
106000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1058000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
770000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
101000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
82000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1568000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
958000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
195000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
153000
CY2022Q1 us-gaap Liabilities
Liabilities
1763000
CY2021Q4 us-gaap Liabilities
Liabilities
1111000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7160000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7160000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
7000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103328000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103111000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81020000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77661000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22315000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25457000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24078000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26568000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2098000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1261000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1261000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1187000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
3359000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2448000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3359000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2448000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3359000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2447000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7160000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5721000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3359000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2447000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
217000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
140000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
23000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
20000
CY2022Q1 us-gaap Depreciation
Depreciation
22000
CY2021Q1 us-gaap Depreciation
Depreciation
18000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
429000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-298000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-433000
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-78000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
591000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
344000
CY2022Q1 bpth Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
24000
CY2021Q1 bpth Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
23000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2526000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1572000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14453000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4157000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18610000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2526000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17038000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23774000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13755000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21248000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30793000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
85000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15070000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14453000
CY2021Q1 bpth Stock Issue During Period Value Warrants Exercised
StockIssueDuringPeriodValueWarrantsExercised
4157000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
140000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2447000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
31373000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25457000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
217000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3359000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22315000
CY2022Q1 bpth Accrued Vacation And Bonus
AccruedVacationAndBonus
500000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
500000
CY2022Q1 bpth Expected Advanced Payment To Be Expensed
ExpectedAdvancedPaymentToBeExpensed
1000000.0
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
400000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
100000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1100000
CY2022Q1 bpth Accrued Manufacturing And Testing Expenses
AccruedManufacturingAndTestingExpenses
300000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
100000
CY2022Q1 bpth Accrued Legal And Patent Fees
AccruedLegalAndPatentFees
100000
CY2022Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
100000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
800000
CY2021Q4 bpth Accrued Vacation And Bonus
AccruedVacationAndBonus
400000
CY2021Q4 bpth Accrued Manufacturing Expense
AccruedManufacturingExpense
100000
CY2021Q4 bpth Accrued Legal And Patent Fees
AccruedLegalAndPatentFees
100000
CY2021Q4 bpth Accrued Manufacturing Expense
AccruedManufacturingExpense
100000
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
100000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.52
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
633000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
11.92
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
243000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.52
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
34000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12200000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0243
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0118
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.27
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.27
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
486000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.58
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
192000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.71
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.02
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
676000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1800000
CY2022Q1 bpth Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Unvested Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndUnvestedWeightedAverageRemainingContractualTerm
P2Y9M18D
CY2022Q1 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
6000000.0

Files In Submission

Name View Source Status
0001558370-22-008980-index-headers.html Edgar Link pending
0001558370-22-008980-index.html Edgar Link pending
0001558370-22-008980.txt Edgar Link pending
0001558370-22-008980-xbrl.zip Edgar Link pending
bpth-20220331.xsd Edgar Link pending
bpth-20220331x10q.htm Edgar Link pending
bpth-20220331x10q_htm.xml Edgar Link completed
bpth-20220331xex10d1.htm Edgar Link pending
bpth-20220331xex31.htm Edgar Link pending
bpth-20220331xex32.htm Edgar Link pending
bpth-20220331_cal.xml Edgar Link unprocessable
bpth-20220331_def.xml Edgar Link unprocessable
bpth-20220331_lab.xml Edgar Link unprocessable
bpth-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending